Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or ...

Blocking structural changes may restore the effectiveness of the cancer drug venetoclax, according to Rutgers Health ...

Blood cancers such as leukemia, lymphoma, and myeloma often begin in the bone marrow and disrupt normal blood cell formation.

Like the surface of the moon, new research published today in Cell finds the existence of craters on the surface of melanoma ...

Cancer cells transfer mitochondria through nanotubes to healthy neighboring cells, turning them into tumor-supporting accomplices, a new study shows.

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells ...

Scientists have created a new light-based cancer therapy that targets tumors precisely without harming healthy cells.

When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...

A new targeted therapy is significantly improving lung cancer patient outcomes. The drug is called Osimertinib, or brand name ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, ...